Clinical Infectious Diseases Advance Access published June 8, 2015
MAJOR ARTICLE
HIV/AIDS
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low HighDensity Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation Michael P. Dubé,1 Lauren Komarow,2 Carl J. Fichtenbaum,3 Joseph J. Cadden,1 Edgar T. Overton,4 Howard N. Hodis,1 Judith S. Currier,5 and James H. Stein6; for the AIDS Clinical Trials Group A5293 Study Team 1
University of Southern California Keck School of Medicine, Los Angeles; 2Harvard School of Public Health, Boston, Massachusetts; 3University of Cincinnati, Ohio; 4University of Alabama at Birmingham; 5University of California at Los Angeles; and 6University of Wisconsin School of Medicine and Public Health, Madison
Background. Low levels of high-density lipoprotein cholesterol (HDL-C) are common in individuals with human immunodeficiency virus (HIV) infection, persist during antiretroviral therapy (ART), and are associated with increased cardiovascular disease (CVD) risk. Methods. Virologically controlled participants without CVD on stable ART with low HDL-C (men